Generation and characterization of chimeric recombinant AAV vectors
Key findings
AAV-ShH10Y445F combines ShH10 capsid with Y445F tyrosine mutation. Enhanced intracellular trafficking through reduced ubiquitination. 2-5 fold improved transduction versus wild-type ShH10 in liver and muscle. Applied in hemophilia B clinical development.